{"id":"W2102718441","doi":"10.1634/theoncologist.2010-0307","title":"Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer","year":2011,"lang":"en","type":"article","venue":"The Oncologist","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":253,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"University of Texas MD Anderson Cancer Center; Merck KGaA","keywords":"Medicine; Keyhole limpet hemocyanin; Cyclophosphamide; Adjuvant; Metastatic breast cancer; Internal medicine; Breast cancer; Population; Seroconversion; Immunology; Cancer; Gastroenterology; Oncology; Chemotherapy; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001660286,0.001372015,0.001545076,0.0002627945,0.0003055746,0.000547502,0.0007371966,0.001179886,0.002453033],"category_scores_gemma":[0.0009650917,0.0003459007,0.0006146544,0.0002662349,0.0008527755,0.0004931678,0.000251372,0.00193517,0.0005521094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008457204,"about_ca_system_score_gemma":0.001662979,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007217217,"about_ca_topic_score_gemma":0.001510443,"domain_scores_codex":[0.9995797,0.0002449443,0.00001884951,0.00006005361,0.00003393495,0.00006250146],"domain_scores_gemma":[0.9993284,0.0001418694,0.0001929569,0.00004373859,0.00004003071,0.000252977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8649816,0.0419811,0.003520349,0.0007102439,0.0004853353,0.0001039491,0.0001099712,0.001788498,0.0362898,0.0001620863,0.001873817,0.04799326],"study_design_scores_gemma":[0.6338742,0.3564224,0.003552197,0.00002397682,0.0001365047,0.0000979462,0.00002000814,0.000775772,0.004095186,0.00009076061,0.0009026351,0.000008573303],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925712,0.002039467,0.0005621061,0.0004248359,0.0001435075,0.002915916,0.000453004,0.00008300837,0.000806926],"genre_scores_gemma":[0.9881707,0.001522809,0.00208218,0.0005954449,0.0002453359,0.004374078,0.001254749,0.0000216963,0.001732946],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002453033,"threshold_uncertainty_score":0.008780539,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1108185418277803,"score_gpt":0.4328358542687114,"score_spread":0.3220173124409311,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}